The U.S. operations of a Swiss pharmaceutical maker has shut down nearly 200 blood plasma donation centers while the company responds to "network issues"
The U.S. operations of a Swiss pharmaceutical maker has shut down nearly 200 blood plasma donation centers while the company responds to "network issues"